Ruminant Diseases and Immunology Research Unit Site Logo
ARS Home About Us Helptop nav spacerContact Us En Espanoltop nav spacer
Printable VersionPrintable Version     E-mail this pageE-mail this page
Agricultural Research Service United States Department of Agriculture
Search
  Advanced Search
 
Programs and Projects
Subjects of Investigation
 

Research Project: COUNTERMEASURES TO CONTROL BACTERIAL DISEASES OF CATTLE

Location: Ruminant Diseases and Immunology Research Unit

Title: Mucosal and parenteral vaccination against pneumonic pasteurellosis in cattle with a modified-live in-frame lktA deletion mutant of Mannheimia haemolytica

Authors
item Briggs, Robert
item Tabatabai, Louisa
item Tatum, Fred

Submitted to: Microbial Pathogenesis
Publication Type: Peer Reviewed Journal
Publication Acceptance Date: February 22, 2012
Publication Date: May 1, 2012
Citation: Briggs, R.E., Tabatabai, L.B., Tatum, F.M. 2012. Mucosal and parenteral vaccination against pneumonic pasteurellosis in cattle with a modified-live in-frame lktA deletion mutant of Mannheimia haemolytica. Microbial Pathogenesis. 52(5):302-309.

Interpretive Summary: A new temperature-conditional plasmid shuttle vector was constructed and utilized to generate a deletion mutant of the bacterium Mannheimia haemolytica, an important causative agent of bovine respiratory disease. The mutant organism no longer produced active leukotoxin, a pivotal virulence factor for the organism, but instead produced a shorter form of inactive leukotoxin effective at inducing immunity. Vaccination by conventional injection, or by applying the live bacteria on cattle feed, effectively made calves resistant to virulent M. haemolytica. Antibody response, reduction in lung lesions, and reduction in infectious load was greater among calves fed the vaccine than those which were injected.

Technical Abstract: A new temperature-conditional shuttle vector, pBB80C, was constructed and utilized to generate an in-frame deletion in the leukotoxin structural gene of Mannheimia haemolytica serotype 1. Culture supernatants from the mutant contained no detectable cytotoxicity to BL-3 lymphocyte targets, and contained a new protein of approximately 66 kDal MW which was reactive to anti-leukotoxin monoclonal antibody. No protein reactive to anti-LktA monoclonal antibody was detected at the 100-105 kDal MW of native LktA. Calves vaccinated mucosally by top-dressing the live mutant onto feed, or parenterally by subcutaneous injection, were resistant to virulent challenge with the parent strain. Serologic antibody response, reduction in lung lesion, and reduction in pulmonary infectious load was greater among calves mucosally vaccinated than those which were vaccinated by injection.

   

 
Project Team
Sacco, Randy
Briggs, Robert - Bob
Tatum, Fred
Nonnecke, Brian
 
Publications
   Publications
 
Related National Programs
  Animal Health (103)
 
 
Last Modified: 05/19/2013
ARS Home | USDA.gov | Site Map | Policies and Links 
FOIA | Accessibility Statement | Privacy Policy | Nondiscrimination Statement | Information Quality | USA.gov | White House